
EyePoint Pharmaceuticals Inc
NASDAQ:EYPT

Intrinsic Value
The intrinsic value of one
EYPT
stock under the Base Case scenario is
3.89
USD.
Compared to the current market price of 5.9 USD,
EyePoint Pharmaceuticals Inc
is
Overvalued by 34%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
EyePoint Pharmaceuticals Inc
Fundamental Analysis


Revenue & Expenses Breakdown
EyePoint Pharmaceuticals Inc
Balance Sheet Decomposition
EyePoint Pharmaceuticals Inc
Current Assets | 383.3m |
Cash & Short-Term Investments | 370.9m |
Receivables | 607k |
Other Current Assets | 11.8m |
Non-Current Assets | 35.2m |
PP&E | 29.2m |
Other Non-Current Assets | 6m |
Free Cash Flow Analysis
EyePoint Pharmaceuticals Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
EyePoint Pharmaceuticals Inc
Revenue
|
43.3m
USD
|
Cost of Revenue
|
-3.7m
USD
|
Gross Profit
|
39.6m
USD
|
Operating Expenses
|
-185.4m
USD
|
Operating Income
|
-145.9m
USD
|
Other Expenses
|
15m
USD
|
Net Income
|
-130.9m
USD
|
EYPT Profitability Score
Profitability Due Diligence
EyePoint Pharmaceuticals Inc's profitability score is 48/100. The higher the profitability score, the more profitable the company is.

Score
EyePoint Pharmaceuticals Inc's profitability score is 48/100. The higher the profitability score, the more profitable the company is.
EYPT Solvency Score
Solvency Due Diligence
EyePoint Pharmaceuticals Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Score
EyePoint Pharmaceuticals Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
EYPT Price Targets Summary
EyePoint Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
EYPT
is 33.66 USD
with a low forecast of 18.18 USD and a high forecast of 71.4 USD.
Dividends
Current shareholder yield for EYPT is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
EYPT
stock under the Base Case scenario is
3.89
USD.
Compared to the current market price of 5.9 USD,
EyePoint Pharmaceuticals Inc
is
Overvalued by 34%.